Skip to main content
Equibles
CRBU logo

CRBU · Caribou Biosciences, Inc. · Metrics

Track CRBU — free

Use CRBU with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CRBU.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.49 +0.03 (+6.36%)
Russell 2000 member Rebalance outlook locked
Market Cap
$49.74M
Shares
107.21M
Volume · Oct 20 885.43K Avg daily vol (3M) 2.4M

CRBU metrics

73 of 116 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.46
Market cap
$49.74M

Price action

20 metrics
Price change (1W)
-6.6%
Price change (30D)
-64.3%
Price change (3M)
-71.4%
Price change (6M)
-79.7%
Price change (YTD)
-70.8%
Price change (1Y)
-82.4%
Trailing year
Price change (5Y)
-97.7%
52-week high
$2.84
52-week low
$0.46
Change from 52-week high
-83.7%
Change from 52-week low
+0.8%
Annualized volatility
82.2%
Annualized volatility (3M)
111.2%
Beta
2.2
RSI (14D)
14.7
Price vs SMA 50
-63.6%
Price vs SMA 200
-72.4%
Avg volume (3M)
2.40M
Relative volume
1.6
Average dollar volume
$2.22M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
107.21M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.3×
reciprocal yield 42.6%
EV / EBITDA
—
EV / EBIT
—
P / sales
5.0×
reciprocal yield 20.2%
P / book
0.5
reciprocal yield 197.2%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-207.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
16.2×
reciprocal yield 6.2%
EV / revenue historical average (5Y)
16.2×
reciprocal yield 6.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-07

Profitability

9 metrics
Gross margin
—
Operating margin
-1,090.9%
Trailing 12 months
Net margin
-1,030.4%
Gross profit (TTM)
—
Operating profit (TTM)
−$109.47M
Net income (TTM)
−$103.40M
Trailing 12 months
Diluted EPS (TTM)
$-1.08
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.11
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-1.14
EBITDA per diluted share (TTM)
$-1.11
Net income per diluted share (TTM)
$-1.08
Operating cash flow per diluted share (TTM)
$-1.00
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.89
Stock compensation per diluted share (TTM)
$0.11
Book value per share
$1.28

Growth

11 metrics
Revenue growth YoY
-43.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$10.04M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+8.6%
Year over year · more shares
Revenue CAGR (3Y)
-7.0%
Revenue CAGR (5Y)
-2.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-105.4%
Return on assets
-72.4%
Debt / equity
0.0
Current ratio
6.5
EBITDA (TTM)
−$106.89M
Free cash flow (TTM)
—
Quick ratio
6.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$26.19M
Latest balance sheet
Cash & equivalents
$26.19M
Total assets
$142.77M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$95.78M
Capital expenditures (TTM)
$389,000
R&D (TTM)
$85.77M
SG&A (TTM)
—
Stock compensation (TTM)
$10.50M
R&D / revenue
854.7%
Stock compensation / revenue
104.7%

Ownership (13F)

3 metrics
13F filers
137
13F filer change QoQ
0
Institutional ownership
45.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
9.8%

Short interest

3 metrics
Short interest
12.0%
Latest settlement · 13.1 days to cover
Days to cover
13.1d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1619856 CUSIP 142038108 13F (30d) 15 filings 15 filers Visit website Investor relations